| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.04▼ | 1.05▼ | 1.05▼ | 1.13▼ | 1.14▼ |
| MA10 | 1.05▼ | 1.05▼ | 1.07▼ | 1.13▼ | 1.15▼ |
| MA20 | 1.05▼ | 1.07▼ | 1.10▼ | 1.16▼ | 1.22▼ |
| MA50 | 1.05▼ | 1.12▼ | 1.13▼ | 1.21▼ | 2.43▼ |
| MA100 | 1.07▼ | 1.13▼ | 1.17▼ | 1.26▼ | 3.48▼ |
| MA200 | 1.11▼ | 1.18▼ | 1.12▼ | 2.26▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.000▼ | -0.006▼ | -0.010▼ | 0.070▲ |
| RSI | 33.324▼ | 29.220▼ | 28.246▼ | 39.872▼ | 36.707▼ |
| STOCH | 11.111▼ | 23.228 | 22.989 | 35.783 | 19.608▼ |
| WILL %R | -100.000▼ | -78.571▼ | -89.286▼ | -92.063▼ | -88.742▼ |
| CCI | -185.470▼ | -110.580▼ | -81.452 | -130.187▼ | -77.760 |
|
Tuesday, May 20, 2025 03:31 AM
Zura Bio Limited, a clinical-stage, multi-asset immunology company dedicated to developing novel dual-pathway antibodies for a range of autoimmune and inflammatory diseases with unmet needs, today ...
|
|
Thursday, May 08, 2025 03:55 AM
ZURA BIO posted quarterly earnings results on Thursday, May 8th.The company reported earnings of -$0.19 per share, missing estimates of -$0.15 by $0.04. The company also reported revenue of $0 ...
|
|
Sunday, April 06, 2025 05:01 PM
Zura Bio Limited (NASDAQ:ZURA – Get Free Report) has been given an average rating of “Buy” by the eight brokerages that are currently covering the firm, MarketBeat reports.One analyst has ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/06/25 | 1.13 | 1.13 | 1.04 | 1.05 | 361,500 |
| 27/06/25 | 1.175 | 1.175 | 1.025 | 1.05 | 5,600,277 |
| 26/06/25 | 1.17 | 1.20 | 1.115 | 1.15 | 242,900 |
| 25/06/25 | 1.22 | 1.22 | 1.15 | 1.18 | 171,700 |
| 24/06/25 | 1.13 | 1.21 | 1.10 | 1.21 | 500,300 |
| 23/06/25 | 1.12 | 1.16 | 1.10 | 1.12 | 328,500 |
| 20/06/25 | 1.11 | 1.20 | 1.11 | 1.13 | 536,800 |
| 18/06/25 | 1.13 | 1.1499 | 1.10 | 1.11 | 308,949 |
| 17/06/25 | 1.19 | 1.20 | 1.14 | 1.14 | 297,719 |
| 16/06/25 | 1.20 | 1.205 | 1.05 | 1.20 | 363,047 |
|
|
||||
|
|
||||
|
|